Noncardiovascular adverse effects associated with amiodarone result in substantial
morbidity. Adverse effects involving the skin, liver, thyroid, and lungs have been reported in …

Background The objective of this study was to determine the association between the use of
antiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts …

Amiodarone is a drug which frequently causes elevated transaminases. However, acute
liver failure has been rarely reported. Here, we present a case of fatal acute liver failure …

Amiodarone was developed in the early 1960s based on extracts from the Khella plant and
was initially used as a coronary dilator for the treatment of angina pectoris (Singh 2008). In …

Acute hepatitis is a very rare, but potentially fatal, adverse effect of intravenous amiodarone.
We present a case of an 88-year-old man with history of ischemic dilated cardiomyopathy …

Drug‐induced liver injury (DILI) is the most frequent cause of post‐marketing warnings and
withdrawals. Amiodarone (AMD), an antiarrhythmic, presents a risk of liver injury in humans …

Estimates from clinical trials and small observational studies of the incidence of pulmonary
toxicity (PT) associated with amiodarone range from 1% to 10%. We report a unique study of …

We present a case report of an 80-year-old woman with volume overload thought initially to
be secondary to heart failure, but determined to be amiodarone-induced acute and chronic …

BACKGROUND: In postmarketing surveillance, the US Food and Drug Administration has
reported the development of lung masses, thyroid cancer, and skin cancer after amiodarone …

Objectives. We sought to assess the odds of experiencing adverse effects with low dose
amiodarone therapy compared with placebo. Background. An estimate of the likelihood of …